Vertex Pharmaceuticals on Track for Record High Close — Data Talk
Vertex Pharmaceuticals Incorporated (VRTX) is currently at $468.98, up $13.64 or 3%
--Would be new all-time high (Based on available data back to July 24, 1991)
--On pace for largest percent increase since Dec. 13, 2023, when it rose 13.23%
--Currently up three consecutive days; up 6.31% over this period
--Best three day stretch since the three days ending Dec. 15, 2023, when it rose 14.8%
--Up 15.26% year-to-date
--Up 40.24% from 52 weeks ago (June 5, 2023), when it closed at $334.42
--Would be a new 52-week closing high
--Up 44.46% from its 52-week closing low of $324.65 on June 7, 2023
--Traded as high as $468.98; new all-time intraday high (Based on available data back to July 24, 1991)
--Up 3% at today's intraday high
--Eighth best performer in the S&P 500 today
--Fifth best performer in the Nasdaq 100 today
All data as of 11:19:10 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 03, 2024 11:36 ET (15:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations